A Study of Patients With HER2 Gene Amplified Metastatic Breast Cancer Treated With First Line Herceptin and a Taxane

NCT00097487 · clinicaltrials.gov ↗
COMPLETED
Status
1000
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Genentech, Inc.